clinical trial · NCT00412867
Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）
StrokeAlteplase
brief summary
The purpose of this study is to confirm the efficacy and safety of intravenously administered alteplase in patients with acute ischemic stroke based on the rate of recanalization assessed by magnetic resonance angiography (MRA), the rate of patients with a modified Rankin Scale (mRS) score of 0-1, and the incidence of symptomatic intracranial hemorrhage (sICH), in comparison with the data reported in the current literature.
started
Dec 1, 2006
primary completion
Jun 1, 2008
completion
Jun 1, 2008
last updated
Jan 5, 2026
official title
Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke (Phase 4)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol